Skip to main content

Table 2 Overview of gepants for the treatment of migraine in alphabetical order

From: Therapeutic novelties in migraine: new drugs, new hope?

Drug Status
Atogepant (AGN-241689, MK-8031) Phase III clinical trials (prophylactic treatment)
BI 44370 Development terminated
MK-3207 Development terminated
Olcegepant (BIBN4096BS) Development terminated
Rimegepant (BMS-927711, BHV3000) Phase III clinical trials (acute treatment); phase II clinical trials (prophylactic treatment)
Telcagepant (MK-0974) Development terminated
Ubrogepant (MK-1602) Phase III clinical trials (acute treatment)
\